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We generated an integration-free, virus-free rhesus macaque
(Macacca mulata) induced pluripotent stem cell (riPSC) line from
rhesus embryonic ﬁbroblasts (REFs). REFs were expanded from embry-
onic skin, which was removed from the torso of an embryonic day 47
rhesus embryo in Carnegie stage 23 (embryo # 34989). The REFs in
this study were called REF89. REF89 cells were reprogrammed using
technology that takes advantage of the non-infectious, self-replicating
Venezuelan equine encephalitis (VEE) virus, which replicates when
the innate interferon immune response is chemically suppressed by re-
combinant B18R during the initial stages of induced reprogramming.
The RNA replicon produces a synthetic RNA containing the
reprograming factors OCT4, KLF4, SOX2, andGLIS1 (OKS-iG) as a polycis-
tronic transcript. Using this technology, we reprogrammed REF89 cells
with VEE-OKS-iGRNA and B18RRNA in the presence of human recombi-
nant B18R protein for eighteen days (Fig. 1A). Pioneering riPSC colonies
ﬁrst appeared between day 14–18, andwere picked on day 21 (Fig. 1A).
Picked colonies were expanded in iPSC media on mytomycin C
inactivated mouse embryonic ﬁbroblasts (MEFs) and split every 5–
7 days. The established riPSC line which originated from a single colony
was called riPSC89 to reﬂect its origin from REF89 (Fig. 1B). riPSC89 and
REF89 were both normal male 42, XY karyotype (Fig. 1C). Non-integra-
tionwas conﬁrmed by genomic PCR taking advantage of a size differen-
tial between endogenous KLF4 (519 bp) and the KLF4 transgene
(416 bp) and absence of the virus-speciﬁc nonstructural protein 2
(NSP2) (Fig. 1D). riPSC89 expressed markers of self-renewal, such as
OCT4, NANOG, SSEA4 and TRA-1-81 (Fig. 1E). In order to assess
pluripotency and differentiation, we performed a teratoma analysis by
injecting undifferentiated colonies of riPSC89 into SCID beige mice.
Using this assay, it was discovered that riPSC89 was competent to
form teratomas, with evidence of ectoderm, mesoderm and endoderm
by histology (Fig.1F).
2. Materials and methods
2.1. Rhesus embryonic ﬁbroblast derivation
The rhesus macaque embryo (embryo # 34989) was obtained from
the time mated breeding (TMB) program at the Oregon National Pri-
mate Research Center (ONPRC) following Institutional Animal Care
and Use Committee Approval. The experimental female and the stud
male were housed together for a total of four days from day 11–14 of
the menstrual cycle. Ovulation was monitored in the female using
serum estradiol to monitor the time of the estradiol peak (ovulation),
which occurred on day 12. The male was removed 48 h later. The day
of fertilization (embryonic day 1) was estimated to occur 48 h after
the serum estradiol peak. Pregnancy was conﬁrmed by measuring
serum progesterone and also by ultrasound. On embryonic day 47
(49 days after the estradiol peak), the embryowas removed by cesarean
section, and Carnegie staging was performed according to Gribnau and
Geijsberts (1981). Skin samples were removed from the torso and
back of the embryo to generate rhesus embryonic ﬁbroblasts (REFs).
The freshly isolated skin samples were digested with 2 mg/mL Collage-
nase IV (Life Technologies) at 37 °C, 5.0% CO2 for 2 h. Digested samples
were centrifuged at 1200 rpm andwashed in DMEM/F12 (Life Technol-
ogies) media prior to plating on 0.1% gelatin (Sigma) coated plates in
Rhesus Fibroblast (RhF) media consisting of DMEM/F12 (Life Technolo-
gies), 15% Fetal bovine serum (GE Healthcare), Non-Essential Amino
Acids (Invitrogen), Glutamax™ (Gibco), Penicillin-Streptomycin-Gluta-
mine (Gibco), and Primocin (Invivogen) at 37 °C, 5.0% CO2. Outgrowths
were monitored for up to 2 weeks (passage 0), with media changes
every 2–3 days. REFs were passaged using 0.25% Trypsin (Gibco) and
were re-plated at a density of 1.5 × 105 cells/well of a 6-well plate
(Corning) on 0.1% gelatin (Sigma). The resulting REF cells were called
REF89.2.2. Generating the riPSC89 line
Reprogramming was performed using the Simplicon™
Reprogramming Kit (EMD Millipore) on REF89 cells at passage 3. One
day before reprogramming, 1.5 × 105 REF89 cells were plated in one
well of a 6-well plate (Corning) coated with 0.1% gelatin (Sigma) in
RhFmedia. On the day of reprogramming, REF89 cells were pre-treated
with theHumanRecombinant B18Rprotein. Cellswere then transfected
once with both B18R RNA and VEE-OKS-iG RNA using the RiboJuice™
mRNA Transfection Kit (EMD Millipore) and allowed to recover over-
night in Stage 1 media (Advanced DMEM (Gibco), 10% FBS (GE
Healthcare), 2 mM L-glutamine (Life Technologies) supplemented
with 200 ng/mL human recombinant B18R protein (EMD Millipore).
From day 1 until day 9 post transfection, 0.1μg/mL Puromycin
(Invivogen) was added to the Stage 1 media, with daily media changes.
Ten days after transfection, REF89 cells were detached using Accumax™
(Sigma) and 1.0 × 105 transfected cells were plated in one well of a 6-
well plate (Corning) on inactivated MEFs in Stage 2 media which con-
sists of MEF conditioned medium (R & D Systems) supplemented with
10 ng/mL bFGF (R&D system), TGF-β RI Kinase Inhibitor IV, Sodium Bu-
tyrate and PS48 (all from Simplicon) and 200 ng/mLB18R protein (EMD
Millipore). Stage 2 media was changed every other day. Small colonies
appeared on day 14 after transfection and by day 18, B18R protein
was removed from the media. Putative riPSC colonies were manually
picked on day 21 and re-plated on inactivated MEFs in regular iPSC
media composed of DMEM/F-12 (Life Technologies), 20% KSR (Life
Technologies), 10 ng/mL bFGF (R & D Systems), 1% nonessential
amino acids (Life Technologies), 2 mM L-Glutamine (Life Technologies),
Primocin™ (Invivogen), and 0.1 mM β-mercaptoethanol (Sigma) on
mytomicin C treated MEFs (passage 0). Seven days later, riPSC colonies
were manually picked and expanded in iPSC media (passage 1). The
riPSC89 line was expanded from a single colony starting at passage 2.
2.3. Karyotyping analysis
REF89 and riPSC89 were karyotyped using metaphase spreads and
G-banding by Cell Line Genetics (Madison, WI).
2.4. Teratoma formation assay
RiPSC89 was digested with 1 mg/mL collagenase IV (Life Technolo-
gies), and the resulting colonies were re-suspended in cold Matrigel
(Corning). riPSC89 colonies in matrigel were injected into the left and
right testis of n = 2 CB17/-Prkdcscid Lystbg/Cr (scid beige) mice using
survival surgery (n = 4 testes total). Each testis was injected with
40 µL of matrigel containing ~2.5 × 106 riPSC89 cells as small clumps.
Twomonths after the transplant, themicewere euthanized and the tes-
tes containing tumors were excised and ﬁxed in 4% Paraformaldehyde
(PFA) in phosphate buffered saline (PBS). The tumors were processed
to parafﬁn for hematoxylin and Eosin (H&E) staining. Diagnosis of tera-
toma was made using an Olympus BX-61 light microscope. All animal
work was ﬁrst approved by the UCLA Ofﬁce of Animal Research
Oversight.
2.5. Immunoﬂuorescence staining
riPSC89 cells were ﬁxed in 4% PFA, permeabilizedwith PBS plus 0.5%
Triton™X-100 (Sigma) then washed in PBST (PBS with 0.1% Tween-20
(Sigma)) and blocked in 10% donkey serum (Jackson Immunoresearch)
for 30min at room temperature. After washing in PBST, cells were incu-
bated overnight at 4 °C with primary antibodies diluted in PBS contain-
ing 2.5% donkey serum. The primary antibody concentrations were,
goat-anti-human OCT4 (1:100, Santa Cruz), goat-anti-human NANOG
(1:100, R&D Systems), mouse-anti-human SSEA-4 (1:100, Develop-
mental Studies Hybridoma Bank), and mouse-anti-human TRA-1-81
(1:100, eBiosciences). After washing in PBST, the cells were incubated
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Fig. 1. Characterization of riPSC89. (A) Timeline of events during the reprogramming REF89 ﬁbroblasts and subsequent establishment and characterization of the riPSC89 cell line from a
single colony. (B) Morphology of the REF89 (Fibroblasts) and a colony of riPSC89 (iPSCs). (C) REF89 and riPSC89 were karyotypically normal male (42, XY). (D) Non-integration after
reprogramming conﬁrmed by PCR of riPSC89 genomic DNA (500 ng). The PCR product originating from endogenous KLF4= 514 bp. The PCR product originating from reprogramming
plasmid KLF4= 418 bp. NSP2 is only present in the plasmid DNA and not riPSC89 gDNA (M = 100 base pair marker with arrow pointing to 500 bp, P = plasmid DNA) *denotes a
non-speciﬁc PCR band of incorrect size. (E) riPSC89 cells express markers of self-renewal such as OCT4 and NANOG, as well as, the cell surface proteins SSEA4 and TRA-1-81. (F)
Pluripotency of riPSC89 was conﬁrmed using a teratoma assay, which contained cell types representing endoderm, mesoderm and ectoderm.
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ing 2.5% donkey serum. For sections stained with primary antibodies
raised in goat, AF594-conjugated donkey anti-goat (1:100, Life Technol-
ogies) was used. For detecting primary antibodies raised in mice,
AF488- or AF594-conjugated donkey-anti-mouse (1:100, Life Technolo-
gies) were used. Cells were then washed in PBST prior to mounting
under coverslips with Prolong Gold Antifade mountant with DAPI (Life
Technologies). Images of cells were acquired with a Zeiss LSM 880 con-
focal laser-scanning microscope. Images were analysed using ImageJ
version 1.51d (NIH).
2.6. PCR of genomic DNA to conﬁrm non-integration
Genomic DNA was isolated from riPSC89 using Quick-gDNA™
miniprep kit (Zymogen). T7-VEE-OKS-iG plasmid DNA (Addgene), was
isolated from bacteria using the plasmid DNA miniprep kit (Qiagen).
At least 500 ng of gDNA was used to conﬁrm non-integration of VEE-
OKS-iG RNA. Primers sets and PCR conditions used for the ampliﬁcation
of the genes NSP2 and KLF4 have been previously reported (Yoshioka et
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